Hofseth BioCare ASA
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Hofseth BioCare ASA generated cash of $2,761,000, which is more than the previous year. Cash used in financing activities reached the amount of $3,694,000 last year. Net change in cash is therefore -$8,537,000.
Cash Flow
| 2014 | -62.25M | -10.32M | 71.18M |
|---|---|---|---|
| 2015 | 7.96M | -12.37M | 30.74M |
| 2016 | -67.22M | -42.10M | 96.62M |
| 2017 | -25.48M | 63.50M | -12.11M |
| 2018 | -28.62M | -9.83M | 45.03M |
| 2019 | -31.06M | -27.16M | 96.57M |
| 2020 | -61.63M | -60.05M | 199.97M |
| 2021 | -61.77M | -37.93M | -23.19M |
| 2022 | -45.16M | -17.77M | 45.45M |
| 2023 | 2.76M | -14.99M | 3.69M |
HBC.OL Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 32.42M | 49.92M | 172.83M | 94.55M | 48.64M | 42.06M | 16.16M | 28.87M | 2.53M | 3.96M |
Operating activities | ||||||||||
Net income | -106.68M | -137.39M | -126.46M | -102.09M | -89.21M | -84.52M | -16.48M | -147.45M | -100.20M | -66.94M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 36.41M | 30.41M | 29.35M | 26.76M | 27.45M | 22.19M | 21.69M | 26.1M | 18.59M | 14.05M |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -778K | -3.98M | 4.17M | -8.72M | 9.15M | 0 | -24.21M | 0 | 42.76M | 0 |
Inventories | 33.98M | -25.71M | -17.51M | -39.31M | -4.58M | -12.54M | -1.27M | 35.22M | 226K | -25.21M |
Accounts payable | 53.40M | 21.58M | 39.20M | 55.24M | -2.4M | 0 | 26.78M | 0 | 25.14M | 0 |
Cash generated by operating activities | 2.76M | -45.16M | -61.77M | -61.63M | -31.06M | -28.62M | -25.48M | -67.22M | 7.96M | -62.25M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | -188K | -6.51M | 0 | 0 | -2.69M | 0 | -537K | -274K |
Investments In Property Plant And Equipment | -8.19M | -17.77M | -37.75M | -54.45M | -28.80M | -9.83M | -13.80M | -42.58M | -11.83M | -10.04M |
Acquisitions Net | -1.61M | 0 | -188K | -6.51M | 0 | 0 | 80M | 0 | -537K | 0 |
Cash generated by investing activities | -14.99M | -17.77M | -37.93M | -60.05M | -27.16M | -9.83M | 63.50M | -42.10M | -12.37M | -10.32M |
Financing activities | ||||||||||
Common Stock Issued | -215K | 70.77M | 0 | 245.64M | 108.93M | 72.21M | 0 | 73.85M | 5.07M | 63.85M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 27.04M | -2.42M | -3.42M | -60.97M | 9.77M | -33.91M | -8.01M | -22.17M | 37.38M | -3.01M |
Cash used in financing activities | 3.69M | 45.45M | -23.19M | 199.97M | 96.57M | 45.03M | -12.11M | 96.62M | 30.74M | 71.18M |
Net Change In Cash | -8.53M | -17.49M | -122.91M | 78.28M | 45.91M | 6.57M | 25.90M | -12.70M | 26.33M | -1.43M |
Cash at end of period | 23.89M | 32.42M | 49.92M | 172.83M | 94.55M | 48.64M | 42.06M | 16.16M | 28.87M | 2.53M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |